CHLA Researcher to Lead First-Ever International Liquid Biopsy Retinoblastoma Study
August 1, 2023
Study will investigate the use of liquid biopsy for diagnosis and determining disease severity.
Content related to A Closer Look: Why Is Research Essential at a Children’s Hospital?
Looking Ahead: A New Frontier in Retinoblastoma
July 31, 2023
International retinoblastoma research study to begin this summer to investigate liquid biopsy and its use in diagnosing and determining disease severity in retinoblastoma.
How a New Test Is Transforming Care for Retinoblastoma
November 13, 2024
Jesse Berry, MD, shares how CHLA’s pioneering liquid biopsy is personalizing care for retinoblastoma.
Upgraded Chemo Propels Luca’s Fight Against Rare Kidney Cancer
September 4, 2024
A more aggressive treatment regimen for clear cell sarcoma has transformed survival rates for children with the disease.
Five Keys to Effective Medication Safety at Home
August 1, 2024
Two CHLA experts explain the steps parents should take to protect their kids from ingesting potentially toxic prescription drugs.
‘I Can See! I Can See!’
July 11, 2019
You will have to grant a parental pardon to Heather for her momentary excessive permissiveness, allowing her 5-year-old daughter to race down the block after dark, free from her mother’s hand. It wasn
Opioids, Methadone and Babies
August 8, 2023
A Children’s Hospital Los Angeles study shows that methadone use following surgery in infants can increase hospital stay and delay recovery.
The VR Technologist Will See You Now
December 5, 2024
A new member of CHLA’s pioneering Interventional Radiology team uses virtual reality to transform minimally invasive procedures for patients and clinicians.
Will N-Acetylcysteine Be the Next Therapy to Prevent Cisplatin-Induced Hearing Loss?
July 24, 2023
A CHLA clinical trial finds that N-acetylcysteine may be a promising next-generation therapy to reduce the risk of cisplatin-induced hearing loss.